Evaluation of the customer issue included a review of the complaint text, a search for similar complaints, labeling review, and accuracy testing.No adverse trend was identified for the customer's issue.Device history review did not identify any issues that may have caused the customer issue.Labeling was reviewed and found to be adequate.The product was not available for return.An internal panel was tested with retained kits of the likely cause reagent lot and accuracy testing met all specifications.A commercially available seroconversion panel (biomex scp-hav-001 formerly known as seroconversion panel rp-004 and distributed by (b)(4)) was tested with retained kits of the likely cause reagent lot and the complaint lot detected the same first bleeds as reactive compared to historical architect havab igm data from biomex.Based on all available information and abbott diagnostics complaint investigation, no product deficiency was identified.
|